128 related articles for article (PubMed ID: 2149020)
1. Haemostatic abnormalities and outcome in patients with operable breast cancer.
McCulloch P; Lowe GD; Douglas JT; Murray GD; George WD
Eur J Cancer; 1990; 26(9):950-3. PubMed ID: 2149020
[TBL] [Abstract][Full Text] [Related]
2. Fibrin(ogen) peptides in early breast cancer.
Mannucci PM; Cugno M; Mameli G; Marongiu F; Bianchi Bonomi A
Thromb Haemost; 1989 Sep; 62(2):819. PubMed ID: 2814934
[No Abstract] [Full Text] [Related]
3. In vivo measurements of fibrin formation and fibrinolysis in operable breast cancer.
McCulloch P; Douglas J; Lowe GD; Murray G; George WD
Thromb Haemost; 1989 Apr; 61(2):318-21. PubMed ID: 2749603
[TBL] [Abstract][Full Text] [Related]
4. [Molecular markers of hemostatic mechanisms--fibrinopeptide A and fibrinopeptide B beta 15-42].
Kobayashi N
Rinsho Byori; 1989 Mar; 37(3):231-3. PubMed ID: 2746916
[No Abstract] [Full Text] [Related]
5. Postoperative changes in hemostasis analyzed by the serial determination of fibrinopeptides and D-dimer.
Kang J; Kambayashi J; Sakon M; Tsujinaka T; Mori T
Jpn J Surg; 1989 May; 19(3):262-8. PubMed ID: 2674499
[TBL] [Abstract][Full Text] [Related]
6. [An analysis of disseminated intravascular coagulation by fibrinopeptides].
Gando S; Tedo I
Rinsho Ketsueki; 1988 Dec; 29(12):2250-5. PubMed ID: 3150013
[No Abstract] [Full Text] [Related]
7. Fibrinopeptide A increases after chorionic villus sampling.
Al-Gailani F; Elias S; Simpson JL; Green D
Prenat Diagn; 1987 Oct; 7(8):557-60. PubMed ID: 3684963
[TBL] [Abstract][Full Text] [Related]
8. Fibrin polymerization sites in fibrinogen and fibrin fragments.
Budzynski AZ; Olexa SA; Pandya BV
Ann N Y Acad Sci; 1983 Jun; 408():301-14. PubMed ID: 6575691
[No Abstract] [Full Text] [Related]
9. The polymerization and thrombin-binding properties of des-(B beta 1-42)-fibrin.
Siebenlist KR; DiOrio JP; Budzynski AZ; Mosesson MW
J Biol Chem; 1990 Oct; 265(30):18650-5. PubMed ID: 2211727
[TBL] [Abstract][Full Text] [Related]
10. Activation of blood coagulation and fibrinolysis in Graves' disease.
Marongiu F; Conti M; Murtas ML; Mameli G; Sorano GG; Martino E
Horm Metab Res; 1991 Dec; 23(12):609-11. PubMed ID: 1778596
[TBL] [Abstract][Full Text] [Related]
11. The effect of low-dose heparin on fibrinopeptide A, platelets, fibrinogen degradation products and other haemostatic parameters measured in connection with intestinal surgery.
Törngren S; Norén I; Savidge G
Thromb Res; 1979; 14(6):871-9. PubMed ID: 382435
[No Abstract] [Full Text] [Related]
12. [Coagulation and fibrinolysis in chronic subdural hematoma. Measurement of fibrinopeptides].
Harada K; Orita T; Abiko S; Aoki H
Neurol Med Chir (Tokyo); 1989 Feb; 29(2):113-6. PubMed ID: 2475799
[TBL] [Abstract][Full Text] [Related]
13. Markers of fibrinogen derivatives used in clinical investigation.
Soria J; Soria C; Mirshahi M; Samama MM
Semin Thromb Hemost; 1985 Apr; 11(2):129-32. PubMed ID: 2412296
[No Abstract] [Full Text] [Related]
14. Fibrin fragment D-dimer and fibrinogen B beta peptides in plasma as markers of clot lysis during thrombolytic therapy in acute myocardial infarction.
Lawler CM; Bovill EG; Stump DC; Collen DJ; Mann KG; Tracy RP
Blood; 1990 Oct; 76(7):1341-8. PubMed ID: 2119827
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen derivatives in plasma.
Lane DA
Br J Haematol; 1981 Mar; 47(3):329-35. PubMed ID: 6161635
[No Abstract] [Full Text] [Related]
16. [Action of proteolytic enzymes on fibrinogen].
Jamet M; Levy G
Ann Anesthesiol Fr; 1978; 19(8):687-91. PubMed ID: 31111
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen, fibrin(ogen) degradation products and fibrinopeptide A in pleural effusions. High turnover of fibrinogen in pleurisy.
Widström O; Kockum C; Nilsson BS
Scand J Respir Dis; 1978 Aug; 59(4):210-5. PubMed ID: 694476
[TBL] [Abstract][Full Text] [Related]
18. Effects of divalent cations on the conversion of fibrinogen to fibrin and fibrin polymerization.
Kanaide H; Uranishi T; Nakamura M
Am J Hematol; 1982 Nov; 13(3):229-37. PubMed ID: 7180836
[TBL] [Abstract][Full Text] [Related]
19. [Interaction of fibrinogen with two forms of fibrin differing in the degree of activation by thrombin].
Belitser VA; Lugovskoĭ EV; Ugarova TP; Derzskaia SG
Biokhimiia; 1985 Aug; 50(8):1336-41. PubMed ID: 4074798
[TBL] [Abstract][Full Text] [Related]
20. Progress in the measurement of circulating fibrinogen derivatives.
Wilner GD
Prog Clin Pathol; 1984; 9():15-45. PubMed ID: 6229812
[No Abstract] [Full Text] [Related]
[Next] [New Search]
